InvestorsHub Logo
Followers 274
Posts 32768
Boards Moderated 0
Alias Born 11/14/2013

Re: None

Sunday, 02/04/2024 7:16:53 AM

Sunday, February 04, 2024 7:16:53 AM

Post# of 708783
Given that ADCs have very limited capability, it is somewhat insane that no less than five large BPs made bids above 35 billion for SeaGen in the year leading up to Pfizer’s purchase of it for 43 billion.

These are companies that know each separate ADC therapy only targets one antigen, and utilizes linked immune suppressing toxic payloads to terminate cells with the targeted antigen.

Of note, towards the end, by September 2022, Merck completely left the bidding.

What happed in September 2022 regarding NWBO?

It submitted its Journal Article to JAMA.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News